Eric Devroe

Chief Operating Officer, Acrivon Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 18, 2026Sold 604 shares at $2.01 of Acrivon Therapeutics, Inc.²
May 18, 2026Granted 72,981 shares of Acrivon Therapeutics, Inc.³
May 14, 2026Shares withheld for tax 613 shares at $1.92 of Acrivon Therapeutics, Inc.⁴
Feb 14, 2026Shares withheld for tax 723 shares at $1.63 of Acrivon Therapeutics, Inc.⁵
Jan 13, 2026Bought 10,000 shares at $1.72 of Acrivon Therapeutics, Inc.⁶
Nov 14, 2025Shares withheld for tax 613 shares at $2.24 of Acrivon Therapeutics, Inc.⁷
Aug 14, 2025Shares withheld for tax 613 shares at $1.39 of Acrivon Therapeutics, Inc.⁸
May 14, 2025Shares withheld for tax 613 shares at $1.14 of Acrivon Therapeutics, Inc.⁹
Feb 14, 2025Shares withheld for tax 724 shares at $5.42 of Acrivon Therapeutics, Inc.¹⁰
Nov 14, 2024Shares withheld for tax 613 shares at $7.92 of Acrivon Therapeutics, Inc.¹¹
Aug 14, 2024Shares withheld for tax 613 shares at $7.02 of Acrivon Therapeutics, Inc.¹²
May 17, 2024Exercised options 10,000 shares at $1.04 of Acrivon Therapeutics, Inc.¹³
May 14, 2024Shares withheld for tax 613 shares at $8.36 of Acrivon Therapeutics, Inc.¹⁴
Feb 14, 2024Shares withheld for tax 723 shares at $3.40 of Acrivon Therapeutics, Inc.¹⁵
Nov 14, 2023Shares withheld for tax 2,450 shares at $5.08 of Acrivon Therapeutics, Inc.¹⁶
Jun 5, 2023Exercised options 9,225 shares at $1.04 of Acrivon Therapeutics, Inc.¹⁷
Nov 14, 2022Granted 33,383 shares of Acrivon Therapeutics, Inc.¹⁸

The numbers on this page point here. Each one links to the record it came from.